![](/img/cover-not-exists.png)
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale
Rajendra H. Mehta, John H. Alexander, Robert Emery, Stephen J. Ellis, Vic Hasselblad, Ahmad Khalil, Michel Carrier, Robert A. Harrington, Jean-Claude TardifVolume:
155
Year:
2008
Language:
english
Pages:
609
DOI:
10.1016/j.ahj.2008.01.002
File:
PDF, 209 KB
english, 2008